Fresita Proteins Limited (BOM:519242)
India · Delayed Price · Currency is INR 133.00
-2.20 (-1.63%)
At close: Oct 6, 2026
Fresita Proteins Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 75.19 | 0.34 | 1.19 | 1.84 | 3.26 |
Cash & Short-Term Investments | 75.1 | 75.19 | 0.34 | 1.19 | 1.84 | 3.26 |
Cash Growth | 22118.05% | 22146.15% | -71.53% | -35.62% | -43.41% | 143.29% |
Accounts Receivable | - | 41.42 | - | - | - | 2.08 |
Receivables | - | 41.42 | - | 21.5 | 20.5 | 19.08 |
Other Current Assets | - | 727.04 | 6.45 | 0.31 | 0.34 | 0.37 |
Total Current Assets | - | 843.65 | 6.79 | 22.99 | 22.68 | 22.7 |
Property, Plant & Equipment | - | 0.06 | - | 0 | 0 | 0 |
Long-Term Deferred Tax Assets | - | 1.2 | 1.2 | 1.36 | 1.35 | 1.81 |
Other Long-Term Assets | - | 0 | - | - | 0.01 | 0.01 |
Total Assets | - | 866.55 | 26.5 | 24.35 | 24.05 | 24.53 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 0.31 | 2.24 | - | - | - |
Accrued Expenses | - | 0.1 | 0.16 | 0.18 | 0.23 | 0.36 |
Current Income Taxes Payable | - | 1.55 | - | - | - | - |
Other Current Liabilities | - | 0.97 | 0.06 | - | - | - |
Total Current Liabilities | - | 2.93 | 2.47 | 0.18 | 0.23 | 0.36 |
Pension & Post-Retirement Benefits | - | - | - | 0.43 | 0.28 | 0.3 |
Other Long-Term Liabilities | - | 1.55 | 0.25 | 0 | - | - |
Total Liabilities | - | 4.48 | 2.72 | 0.62 | 0.51 | 0.66 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 89.76 | 17.26 | 17.26 | 17.26 | 17.26 |
Additional Paid-In Capital | - | 761.25 | - | - | - | - |
Retained Earnings | - | 3.28 | -1.27 | -1.32 | -1.51 | -1.18 |
Comprehensive Income & Other | - | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 |
Shareholders' Equity | 30.16 | 862.07 | 23.78 | 23.73 | 23.53 | 23.87 |
Total Liabilities & Equity | - | 866.55 | 26.5 | 24.35 | 24.05 | 24.53 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 1.55 | - | - | - | - | - |
Net Cash (Debt) | 73.55 | 75.19 | 0.34 | 1.19 | 1.84 | 3.26 |
Net Cash Growth | 21659.47% | 22146.15% | -71.53% | -35.62% | -43.41% | 143.29% |
Net Cash Per Share | 20.80 | 14.05 | 0.20 | 0.69 | 1.07 | 1.89 |
Filing Date Shares Outstanding | 8.97 | 8.98 | 1.73 | 1.73 | 1.73 | 1.73 |
Total Common Shares Outstanding | 8.97 | 8.98 | 1.73 | 1.73 | 1.73 | 1.73 |
Working Capital | - | 840.72 | 4.33 | 22.81 | 22.45 | 22.34 |
Book Value Per Share | 17.49 | 96.04 | 13.78 | 13.75 | 13.64 | 13.83 |
Tangible Book Value | 30.16 | 862.07 | 23.78 | 23.73 | 23.53 | 23.87 |
Tangible Book Value Per Share | 17.49 | 96.04 | 13.78 | 13.75 | 13.64 | 13.83 |
Machinery | - | 0.1 | - | 0.02 | 0.02 | 0.02 |